Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes

被引:14
|
作者
Soholm, Julie C. [1 ]
Vestgaard, Marianne [1 ,2 ,3 ]
Asbjornsdottir, Bjorg [1 ,2 ,4 ]
Do, Nicoline C. [1 ,2 ,4 ]
Pedersen, Berit W. [1 ,3 ,4 ]
Storgaard, Lone [1 ,3 ,4 ]
Nielsen, Birgitte B. [1 ,3 ,4 ]
Ringholm, Lene [1 ,2 ]
Damm, Peter [1 ,3 ,4 ]
Mathiesen, Elisabeth R. [1 ,2 ,4 ]
机构
[1] Rigshosp, Ctr Pregnant Women Diabet, Copenhagen, Denmark
[2] Rigshosp, Dept Endocrinol, Copenhagen, Denmark
[3] Rigshosp, Dept Obstet, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
关键词
Blood pressure; Diabetes; Fetal overgrowth; Gestational weight gain; Glycaemic control; Hypertension; Preeclampsia; Pregnancy outcome; Preterm delivery; FALLING INSULIN REQUIREMENTS; PREGNANT-WOMEN; GLYCEMIC CONTROL; FETAL-GROWTH; WEIGHT-GAIN; OUTCOMES; NEPHROPATHY; MICROALBUMINURIA; PREECLAMPSIA; MANAGEMENT;
D O I
10.1007/s00125-021-05482-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis: We aimed to identify potentially modifiable risk factors and causes for preterm delivery in women with type 1 or type 2 (pre-existing) diabetes. Methods: A secondary analysis of a prospective cohort study of 203 women with pre-existing diabetes (117 type 1 and 86 type 2 diabetes) was performed. Consecutive singleton pregnancies were included at the first antenatal visit between September 2015 and February 2018. Results: In total, 27% (n = 55) of the 203 women delivered preterm at median 36 + 0 weeks. When stratified by diabetes type, 33% of women with type 1 diabetes delivered preterm compared with 20% in women with type 2 diabetes (p = 0.04). Women delivering preterm were characterised by a higher prevalence of pre-existing kidney involvement (microalbuminuria or diabetic nephropathy) (16% vs 3%, p = 0.002), preeclampsia (26% vs 5%, p < 0.001), higher positive ultrasound estimated fetal weight deviation at 27 gestational weeks (2.7% vs -1.6% from the mean, p = 0.008), higher gestational weight gain (399 g/week vs 329 g/week, p = 0.01) and similar HbA(1c) levels in early pregnancy (51 mmol/mol [6.8%] vs 49 [6.6%], p = 0.22) when compared with women delivering at term. Independent risk factors for preterm delivery were pre-existing kidney involvement (OR 12.71 [95% CI 3.0, 53.79]), higher gestational weight gain (per 100 g/week, OR 1.25 [1.02, 1.54]), higher positive ultrasound estimated fetal weight deviation at 27 gestational weeks (% from the mean, OR 1.07 [1.03, 1.12]) and preeclampsia (OR 7.04 [2.34, 21.19]). Two-thirds of preterm deliveries were indicated and one-third were spontaneous. Several contributing factors to indicated preterm delivery were often present in each woman. The main indications were suspected fetal asphyxia (45%), hypertensive disorders (34%), fetal overgrowth (13%) and maternal indications (8%). Suspected fetal asphyxia mainly included falling insulin requirement and abnormal fetal haemodynamics. Conclusions/interpretations: Presence of preeclampsia, higher positive ultrasound estimated fetal weight deviation at 27 gestational weeks and higher gestational weight gain were independent potentially modifiable risk factors for preterm delivery in this cohort of women with pre-existing diabetes. Indicated preterm delivery was common with suspected fetal asphyxia or preeclampsia as the most prevalent causes. Prospective studies evaluating whether modifying these predictors will reduce the prevalence of preterm delivery are warranted.
引用
收藏
页码:1939 / 1948
页数:10
相关论文
共 50 条
  • [1] Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes
    Julie C. Søholm
    Marianne Vestgaard
    Björg Ásbjörnsdóttir
    Nicoline C. Do
    Berit W. Pedersen
    Lone Storgaard
    Birgitte B. Nielsen
    Lene Ringholm
    Peter Damm
    Elisabeth R. Mathiesen
    Diabetologia, 2021, 64 : 1939 - 1948
  • [2] Factors associated with preterm delivery in women with type 1 diabetes
    不详
    DIABETES MELLITUS, 2005, 8 (04): : 64 - 64
  • [3] Factors associated with preterm delivery in women with type 1 diabetes - A cohort study
    Lepercq, J
    Coste, J
    Theau, A
    Dubois-Laforgue, D
    Timsit, J
    DIABETES CARE, 2004, 27 (12) : 2824 - 2828
  • [4] THE RELATIVE IMPORTANCE OF MODIFIABLE RISK FACTORS OF TYPE 2 DIABETES
    Laaksonen, Maarit A.
    Knekt, Pau
    Rissanen, Harri
    Virtala, Esa
    Marniemi, Jukka
    Harkanen, Tommi
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 406 - 406
  • [5] Modifiable Factors Associated with Bone in Premenopausal Women with Type 1 Diabetes
    Kujath, Amber S.
    Danielson, Kirstie K.
    Quinn, Lauretta
    Palta, Mari
    DIABETES, 2011, 60 : A352 - A352
  • [6] UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes
    Adler, AI
    Stevens, RJ
    Neil, A
    Stratton, IM
    Boulton, AJM
    Holman, RR
    DIABETES CARE, 2002, 25 (05) : 894 - 899
  • [7] Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes
    Dhurandhar, Nikhil V.
    Akheruzzaman, Md
    Hegde, Vijay
    NUTRITION & DIABETES, 2020, 10 (01)
  • [8] Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes
    Nikhil V. Dhurandhar
    Md Akheruzzaman
    Vijay Hegde
    Nutrition & Diabetes, 10
  • [9] Type II diabetes and breast cancer; a potentially modifiable risk factor?
    Jones, K.
    George, K. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S178 - S178
  • [10] The role of modifiable pre-pregnancy risk factors in preventing adverse fetal outcomes among women with type 1 and type 2 diabetes
    Inkster, Melanie E.
    Fahey, Tom P.
    Donnan, Peter T.
    Leese, Graham P.
    Mires, Gary J.
    Murphy, Deirdre J.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (10) : 1153 - 1157